NCT00107250 - AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 21, 2005

Primary Completion Date

October 23, 2009

Study Completion Date

January 18, 2011

Conditions

Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

capecitabine

1000 mg/m2 orally twice daily (total of 2000 mg/m2 per day) for the first 14 days of a 21 day cycle for a maximum of 6-8 cycles.

DRUG

carboplatin

AUC 6; IV; 30 minutes; Every 21 days for a maximum of 6-8 cycles

DRUG

cediranib maleate

Given daily; orally with approximately 240 ml of water whilst in an upright position

DRUG

paclitaxel

200mg/m2; IV; 3 hours; Every 21 days for a maximum of 6-8 cycles

Trial Locations (2)

Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa

Princess Margaret Hospital, Toronto